Literature DB >> 26045900

Knockdown of YEATS4 inhibits colorectal cancer cell proliferation and induces apoptosis.

Kun Tao1, Jing Yang2, Yuemei Hu2, Anmei Deng3.   

Abstract

YEATS domain containing 4 (YEATS4) is usually amplified and functions as an oncogene in human glioma. However, the biological role of YEATS4 in colorectal cancer (CRC) has not yet been discussed. In this study, we investigated the expression level of YEATS4 in 85 pairs of CRC and paracancerous tissues, and knocked down YEATS4 via a lentivirus system in RKO CRC cell line. Although YEATS4 was upregulated in CRC tissues, YEATS4 expression showed no association with any clinical features and overall survival. Inhibition of YEATS4 significantly suppressed cell proliferation and colony formation. Flow cytometry revealed that cell cycle was arrested in the G0/G1 phase and the number of apoptotic cells were significantly increased when YEATS4 expression was inhibited. In conclusion, our findings provide first evidence that YEATS4 may be an important regulator of cell proliferation and apoptosis in CRC cells.

Entities:  

Keywords:  YEATS domain containing 4; apoptosis; cell cycle; colorectal cancer; proliferation

Year:  2015        PMID: 26045900      PMCID: PMC4448200     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  19 in total

1.  The mammalian YL1 protein is a shared subunit of the TRRAP/TIP60 histone acetyltransferase and SRCAP complexes.

Authors:  Yong Cai; Jingji Jin; Laurence Florens; Selene K Swanson; Thomas Kusch; Bing Li; Jerry L Workman; Michael P Washburn; Ronald C Conaway; Joan Weliky Conaway
Journal:  J Biol Chem       Date:  2005-01-11       Impact factor: 5.157

2.  GAS41 is required for repression of the p53 tumor suppressor pathway during normal cellular proliferation.

Authors:  Jeong Hyeon Park; Robert G Roeder
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

3.  GAS41 amplification results in overexpression of a new spindle pole protein.

Authors:  Jana Schmitt; Ulrike Fischer; Sabrina Heisel; Hilmar Strickfaden; Christina Backes; Alessia Ruggieri; Andreas Keller; Paul Chang; Eckart Meese
Journal:  Genes Chromosomes Cancer       Date:  2012-05-23       Impact factor: 5.006

4.  YEATS4 is a novel oncogene amplified in non-small cell lung cancer that regulates the p53 pathway.

Authors:  Larissa A Pikor; William W Lockwood; Kelsie L Thu; Emily A Vucic; Raj Chari; Adi F Gazdar; Stephen Lam; Wan L Lam
Journal:  Cancer Res       Date:  2013-10-29       Impact factor: 12.701

5.  Interaction of the transforming acidic coiled-coil 1 (TACC1) protein with ch-TOG and GAS41/NuBI1 suggests multiple TACC1-containing protein complexes in human cells.

Authors:  Brenda Lauffart; Scott J Howell; Jason E Tasch; John K Cowell; Ivan H Still
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

6.  Targeted disruption of the GAS41 gene encoding a putative transcription factor indicates that GAS41 is essential for cell viability.

Authors:  Katrin Zimmermann; Katja Ahrens; Siegfried Matthes; Jean-Marie Buerstedde; Wolf H Strätling; Loc Phi-van
Journal:  J Biol Chem       Date:  2002-03-18       Impact factor: 5.157

7.  Cloning of a novel transcription factor-like gene amplified in human glioma including astrocytoma grade I.

Authors:  U Fischer; D Heckel; A Michel; M Janka; T Hulsebos; E Meese
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150

8.  Twelve amplified and expressed genes localized in a single domain in glioma.

Authors:  U Fischer; P Meltzer; E Meese
Journal:  Hum Genet       Date:  1996-11       Impact factor: 4.132

9.  Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.

Authors:  Jordi Barretina; Barry S Taylor; Shantanu Banerji; Alexis H Ramos; Mariana Lagos-Quintana; Penelope L Decarolis; Kinjal Shah; Nicholas D Socci; Barbara A Weir; Alan Ho; Derek Y Chiang; Boris Reva; Craig H Mermel; Gad Getz; Yevgenyi Antipin; Rameen Beroukhim; John E Major; Charles Hatton; Richard Nicoletti; Megan Hanna; Ted Sharpe; Tim J Fennell; Kristian Cibulskis; Robert C Onofrio; Tsuyoshi Saito; Neerav Shukla; Christopher Lau; Sven Nelander; Serena J Silver; Carrie Sougnez; Agnes Viale; Wendy Winckler; Robert G Maki; Levi A Garraway; Alex Lash; Heidi Greulich; David E Root; William R Sellers; Gary K Schwartz; Cristina R Antonescu; Eric S Lander; Harold E Varmus; Marc Ladanyi; Chris Sander; Matthew Meyerson; Samuel Singer
Journal:  Nat Genet       Date:  2010-07-04       Impact factor: 38.330

10.  The YEATS family member GAS41 interacts with the general transcription factor TFIIF.

Authors:  Sabrina Heisel; Nunja C Habel; Nicole Schuetz; Alessia Ruggieri; Eckart Meese
Journal:  BMC Mol Biol       Date:  2010-07-12       Impact factor: 2.946

View more
  5 in total

1.  Abnormal expression of YEATS4 associates with poor prognosis and promotes cell proliferation of hepatic carcinoma cell by regulation the TCEA1/DDX3 axis.

Authors:  Song You; Fuqiang Wang; Qing Hu; Pengtao Li; Changmao Zhang; Yaqi Yu; Yi Zhang; Qiu Li; Qing Bao; Pingguo Liu; Jie Li
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

2.  YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.

Authors:  Chen Jixiang; Dang Shengchun; Qu Jianguo; Mao Zhengfa; Fan Xin; Wang Xuqing; Zhang Jianxin; Cui Lei
Journal:  Oncotarget       Date:  2017-04-11

3.  YEATS Domain Containing 4 Promotes Gastric Cancer Cell Proliferation and Mediates Tumor Progression via Activating the Wnt/β-Catenin Signaling Pathway.

Authors:  Sheqing Ji; Youxiang Zhang; Binhai Yang
Journal:  Oncol Res       Date:  2017-03-02       Impact factor: 5.574

4.  Development of potent dimeric inhibitors of GAS41 YEATS domain.

Authors:  Dymytrii Listunov; Brian M Linhares; EunGi Kim; Alyssa Winkler; Miranda L Simes; Sidney Weaver; Hyo Je Cho; Alexandrea Rizo; Sergey Zolov; Venkateshwar G Keshamouni; Jolanta Grembecka; Tomasz Cierpicki
Journal:  Cell Chem Biol       Date:  2021-07-21       Impact factor: 8.116

5.  BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion.

Authors:  Alexandra M Blee; Shujun Liu; Liguo Wang; Haojie Huang
Journal:  Oncotarget       Date:  2016-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.